BackChina SXT Pharmaceuticals Overview

China SXT Pharmaceuticals Cost of Revenue

Cost of Revenue analysis for SXTC.

Quarterly Cost of Revenue

$339372.00
↓ 6.16% YoY

As of Mar 31, 2025

Annual Cost of Revenue (TTM)

$1.37M
↓ 23.82% YoY

Trailing 12 months ending Mar 31, 2025

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin